5.65
Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten
EDSA Stock Soars More Than 700% So Far This Year: Wall Street Eyes Further Upside In Run Up To Acute Kidney Injury Data Reveal - Stocktwits
EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits
Edesa Biotech (NASDAQ:EDSA) Posts Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat
Edesa Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K EDESA BIOTECH For: 13 August By Investing.com - Investing.com South Africa
Edesa Biotech Q3 loss widens 140% to $5.4M on rising R&D spend - scanx.trade
Edesa Biotech (EDSA) loss widens to $11.9M as R&D surges and cash tightens - Stock Titan
Edesa Reports $5.4 Million Q3 Loss as EB06 Phase 2 Site Activation Begins - Quiver Quantitative
Edesa Starts Activating First Vitiligo Trial Sites as Enrollment Nears - Stock Titan
Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Why Did EDSA Stock Rally More Than 70% Today? - Stocktwits
Edesa Biotech (EDSA) to Post Earnings on Monday - MarketBeat
Edesa Biotech Inc (EDSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EDSA Q3'26 Earnings: EPS estimate is (0.43) USD - TradingView
Edesa Biotech (NASDAQ: EDSA) CEO receives 5,324 restricted share units - Stock Titan
EDSA Q3'26 Earnings: revenue estimate is 0 USD - TradingView
Edesa Biotech Inc (EDSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Edesa Biotech Inc (EDSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Edesa Biotech Inc (EDSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Edesa Biotech Inc (EDSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Edesa Biotech Inc (EDSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edesa Biotech Inc (EDSA) Income Statement - TradingKey
Edesa Biotech (EDSA) Edges Lower Amid Thin Trading: Key Levels in FocusAndrews Pitchfork - dars.gov.et
Edesa Biotech Market Sentiment - Benzinga España
Edesa Biotech Inc (EDSA) Institutional Confidence - TradingKey
Edesa Biotech Inc (EDSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EDSA|Edesa Biotech Inc|Price:5.250|Chg%:-0.410 - TradingKey
Edesa Biotech (EDSA) Slips 7% as Stock Retests Key Support Near $5.00Anchored VWAP - dars.gov.et
TradingKey - TradingKey
Edesa Biotech Inc (EDSA) Balance Sheet - TradingKey
Edesa Biotech, Inc. Revenue Breakdown – NASDAQ:EDSA - TradingView
Edesa Biotech Inc (EDSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Edesa Biotech (EDSA) Revenue BreakdownMain Composition - Moomoo
Edesa Biotech, Inc. SEC Filing (Jul 14, 2026) - Stock Titan
Edesa Biotech (EDSA) details $3.5M private placement and 729,241-share resale - Stock Titan
Edesa Biotech | 424B3: Prospectus - Moomoo
Edesa Biotech (EDSA) Holds Steady Near Support After Minimal GainsInstitutional Volume - dars.gov.et
Enterprise value to EBIT forward of Edesa Biotech, Inc. – NASDAQ:EDSA - TradingView
Edesa Biotech Company Profile & Introduction - Moomoo
Edesa Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Nijhawan Pardeep - Moomoo
EDSA Should I Buy - Intellectia AI
Form S-3 EDESA BIOTECH For: 2 July By Investing.com - Investing.com Nigeria
Edesa Biotech (EDSA) CEO receives 3,378-share RSU grant - Stock Titan
Edesa Biotech (NASDAQ: EDSA) registers 729,241 shares for resale - Stock Titan
EDSA: Positive Exploratory Data in Patients with AKI - Yahoo Finance
Edesa Biotech Inc. (EDSA) Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesShare Repurchase Impact - dars.gov.et
Brookline Capital Initiates Edesa Biotech(EDSA.US) With Buy Rating, Announces Target Price $21 - Moomoo
Brookline initiates Edesa Biotech stock with buy on pipeline By Investing.com - Investing.com Nigeria
Brookline initiates Edesa Biotech stock with buy on pipeline - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):